Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rogatko

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Mutagens, N-nitroso compounds and their precursors in gastric juice from patients with and without precancerous lesions of the stomachB Pignatelli, C Malaveille, A Rogatko, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 20, 1999
Exploring family relationships in cancer risk counseling using the genogramM Daly, J Farmer, C Harrop-Stein, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Phase I study of phosphonacetyl-L-aspartate, 5-fluorouracil, and leucovorin in patients with advanced cancerA Hageboutros, A Rogatko, E M Newman, et al.
Sarcoma|June 4, 2008
Phase II Trial of Dolastatin-10, a Novel Anti-Tubulin Agent, in Metastatic Soft Tissue SarcomasM von Mehren, S P Balcerzak, A S Kraft, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomasM von Mehren, P Arlen, K Y Tsang, et al.
Urology|July 11, 2001
Phase I trial of weekly paclitaxel plus oral estramustine phosphate in patients with hormone-refractory prostate cancerN Haas, B Roth, C Garay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Evaluation of carboplatin pharmacokinetics in the absence and presence of paclitaxelC K Obasaju, S W Johnson, A Rogatko, et al.
Cancer Research|February 1, 1994
Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 scheduleR J Schilder, F P LaCreta, R P Perez, et al.
International Journal of Oncology|September 24, 1999
Allelic instability as a predictor of survival in Egyptian breast cancer patientsA R Zekri, A A Bahnassi, B Bove, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinomaM von Mehren, P Arlen, J Gulley, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Mutagens, N-nitroso compounds and their precursors in gastric juice from patients with and without precancerous lesions of the stomachB Pignatelli, C Malaveille, A Rogatko, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 20, 1999
Exploring family relationships in cancer risk counseling using the genogramM Daly, J Farmer, C Harrop-Stein, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Phase I study of phosphonacetyl-L-aspartate, 5-fluorouracil, and leucovorin in patients with advanced cancerA Hageboutros, A Rogatko, E M Newman, et al.
Sarcoma|June 4, 2008
Phase II Trial of Dolastatin-10, a Novel Anti-Tubulin Agent, in Metastatic Soft Tissue SarcomasM von Mehren, S P Balcerzak, A S Kraft, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomasM von Mehren, P Arlen, K Y Tsang, et al.
Urology|July 11, 2001
Phase I trial of weekly paclitaxel plus oral estramustine phosphate in patients with hormone-refractory prostate cancerN Haas, B Roth, C Garay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Evaluation of carboplatin pharmacokinetics in the absence and presence of paclitaxelC K Obasaju, S W Johnson, A Rogatko, et al.
Cancer Research|February 1, 1994
Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 scheduleR J Schilder, F P LaCreta, R P Perez, et al.
International Journal of Oncology|September 24, 1999
Allelic instability as a predictor of survival in Egyptian breast cancer patientsA R Zekri, A A Bahnassi, B Bove, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinomaM von Mehren, P Arlen, J Gulley, et al.
Pageof 6